Cesarean. Encounter for cesarean delivery without indication
Conditions
Interventions
Intervention 1: Intervention group: Daily conjugated estrogen vaginal cream (one applicator) vaginally for 3 consecutive weeks. Intervention 2: Intervention group: Taking evening primrose tablets (man
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women who are candidates for colposcopy and have an unsatisfactory colposcopy
Exclusion criteria
Exclusion criteria: Cervical structural anomalies such as history of cervical insufficiency, Müllerian anomaly and history of conization Having contraindications or sensitivity to evening primrose or estradiol Cancer in the patient or a history of breast or ovarian cancer in the family History of smoking Active vaginal bleeding or pregnancy Post-menopausal women with an inflammatory pap smear or persistent vaginal discharge Taking aspirin or Flavix History of cardiovascular diseases and thromboembolism, sexually transmitted diseases, digestive diseases and neurological diseases, hypertension and coagulopathy, liver disease Thyroid dysfunction and thyroid medication use Blood disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Satisfactoryness of colposcopy. Timepoint: 4 weeks after the start of drug administration. Method of measurement: colposcopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects such as stomach pain, breast pain, bloating, headache, itching, nausea and vomiting, diarrhea, chest or leg pain, impaired vision or speech, skin sensitivity, abnormal vaginal bleeding, vaginal itching and irritation. Timepoint: 4 weeks after the start of drug administration. Method of measurement: Ask the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Afsaneh Tehranian
Tehran University of Medical Sciences
Outcome results
None listed